Abstract:Diabetic retinopathy (DR) is a leading cause of irreversible blindness in the working-age populations. Despite decades of research on the pathogenesis of DR for clinical care, a comprehensive understanding of the condition is still lacking due to the intricate cellular diversity and molecular heterogeneity involved. Single-cell RNA sequencing (scRNA-seq) has made the high-throughput molecular profiling of cells across modalities possible which has provided valuable insights into complex biological systems. In this review, we summarise the application of scRNA-seq in investigating the pathogenesis of DR, focusing on four aspects. These include the identification of differentially expressed genes, characterisation of key cell subpopulations and reconstruction of developmental 'trajectories' to unveil their state transition, exploration of complex cell-cell communication in DR and integration of scRNA-seq with genome-wide association studies to identify cell types that are most closely related to DR risk genetic loci. Finally, we discuss the future challenges and expectations associated with studying DR using scRNA-seq. We anticipate that scRNA-seq will facilitate the discovery of mechanisms and new treatment targets in the clinical care landscape for patients with DR.Key points Progress in scRNA-seq for diabetic retinopathy (DR) research includes studies on DR patients, non-human primates, and the prevalent mouse models. scRNA-seq facilitates the identification of differentially expressed genes, pivotal cell subpopulations, and complex cell-cell interactions in DR at single-cell level. Future scRNA-seq applications in DR should target specific patient subsets and integrate with single-cell and spatial multi-omics approaches. scRNA-seq provides novel insights into the pathogenesis of diabetic retinopathy, including identification of differentially expressed genes, characterisation of key cell subpopulations, construction of cell state transition trajectories and exploration of intricate cell-cell communication. image

Non-coding RNAs and exosomal non-coding RNAs in diabetic retinopathy: A narrative review

Roles of noncoding RNAs in diabetic retinopathy: Mechanisms and therapeutic implications

Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017–2022)

Mechanistic and therapeutic perspectives of non-coding RNA-modulated apoptotic signaling in diabetic retinopathy

Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy

Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy

Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation

Roles of Mirnas and Long Noncoding RNAs in the Progression of Diabetic Retinopathy

Emerging role of extracellular vesicles in diabetic retinopathy

Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy

Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications

Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy

The exosome-transmitted lncRNA LOC100132249 induces endothelial dysfunction in diabetic retinopathy

Research Progress on Exosomes/micrornas in the Treatment of Diabetic Retinopathy

Single-cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy

Role of extracellular vesicle miRNA in pathogenesis of diabetic retinopathy

In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy

Single-cell transcriptomes reveal a molecular link between diabetic kidney and retinal lesions

Epigenetic Mechanisms in the Pathogenesis of Diabetic Retinopathy

Expression profiles of circRNAs, lncRNAs, and mRNAs in extreme phenotypes of diabetic retinopathy

Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas